(4-(Piperazin-1-yl)phenyl)boronic acid, 95.0%, 5g

N-(3-Chlorophenyl)-2-chloropropanamide, 98%, 2g

Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-, hydrochloride (1:1), 98%, 100mg

Methyl 5-amino-4,6-dichloropicolinate, 98%, 1g

3,4-Diisopropoxy-3-cyclobutene-1,2-dione, 98.0%, 1g

2-Amino-4-methoxybenzamide, 98%, 100mg

(S,E)-2-(benzylideneamino)-3-phenylpropan-1-ol, 97%, 1g

Di-potassium oxalate monohydrate, min. 98.5%, pa, ACS, 250 g, plastic packaging.

8-Bromo-6-methylquinazolin-4(3H)-one, 95.0%, 5g

3,7,10-Trimethyl-2,8,9-trioxa-5-aza-1-borabicyclo[3.3.3]undecane, 95.0%, 25g

2-Fluorobenzoyl Chloride>98.0%(GC)(T)500g

rel-(3R,4S)-1-(tert-Butoxycarbonyl)-4-(p-tolyl)pyrrolidine-3-carboxylic acid, 98%, 1g

8-Bromo-1,6-naphthyridine, 97.0%, 1g